Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Alpine Immune Sciences Initiates Trial Collaboration With Merck

Alpine Immune Sciences Inc (NASDAQ:ALPN) has entered into a clinical trial collaboration and supply agreement with Merck & Co Inc (NYSE:MRK).  This collaboration…
byVandana Singh
June 30, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0
  • Alpine Immune Sciences Inc (NASDAQ:ALPN) has entered into a clinical trial collaboration and supply agreement with Merck & Co Inc (NYSE:MRK). 
  • This collaboration will evaluate the safety and efficacy of Alpine’s ALPN-202 in combination with Merck’s Keytruda (pembrolizumab) in patients with advanced malignancies.
  • Dubbed as NEON-2, the trial is currently enrolling.
  • Price Action: ALPN shares are down 1.93% at $8.92 during the market session on the last check Wednesday.
 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

5 Value Stocks In The Consumer Defensive Sector

By Benzinga Insights
Today, 5:14 AM
Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

ACU